Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review.

Korean J Intern Med · 2022 · PMC9271724 · PMID 35421909

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Changes in antiphospholipase A2 receptor antibody Only seven patients (Patients 7–13) had data for serum anti-PLA2R-Ab titer when they were treated with RTX; only Patient 13 had a negative serum anti-PLA2R-Ab level ( Table 2 ), whereas the other six patients had a positive anti-PLA2R-Ab titer (median titer, 80.1 RU/mL; IQR, 45.1 to 428.9) and showed a decreasing trend of antibody titer from RTX initiation to the last follow-up.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.